NCT04083625View on ClinicalTrials.gov

the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

September 10, 2019

Primary Completion Date

February 10, 2020

Study Completion Date

February 20, 2020

Conditions
Abdominal Myomectomy
Interventions
DRUG

carbetocin 100 mcg

a 10 cm syringe containing 100 mcg carbetocin just before skin incision of myomectomy.

DRUG

placebo

a 10 cm syringe normal saline IV given just before skin incision of myomectomy.

Trial Locations (1)

11231

Giza hospital, Giza

All Listed Sponsors
lead

Cairo University

OTHER

NCT04083625 - the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy | Biotech Hunter | Biotech Hunter